IP Library › Assignment 050111/0212
Patent Assignment
Reel/Frame 050111/0212

Corrective Assignment to Correct the City of the Assignee from Wadenswil to WäDenswil Previously Recorded on Reel 049922 Frame 0697. Assignor(S) Hereby Confirms the Merger.

Recorded: 2019-08-20 Pages: 7
Assignor
NUMAB INNOVATION AG
Executed: 2019-05-07
Assignee
NUMAB THERAPEUTICS AG
EINSIEDLERSTRASSE 34, WÄDENSWIL, 8820, SWITZERLAND
Covered Properties (3)
Hetero-Dimeric Multi-Specific Antibody Format
Application: 15/736,747 →
Publication: US 2018/0355024
Anti-TNFalpha-Antibodies and Functional Fragments Thereof
Application: 16/085,567 →
Publication: US 2019/0092850
Novel Antibody Frameworks
Application: 16/156,036 →
Publication: US 2019/0119359
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 17, 2018
From: URECH, DAVID; MEYER, SEBASTIAN
To: NUMAB INNOVATION AG
Reel/Frame 045263/0478 →
Assignment of Assignor's Interest Oct 10, 2018
From: MEYER, SEBASTIAN; URECH, DAVID
To: NUMAB AG
Reel/Frame 047119/0128 →
Change of Name Oct 10, 2018
From: NUMAB AG
To: NUMAB INNOVATION AG
Reel/Frame 047119/0205 →
Assignment of Assignor's Interest Oct 16, 2018
From: GUNDE, TEA; MEYER, SEBASTIAN
To: NUMAB INNOVATION AG
Reel/Frame 047175/0642 →
Merger Jul 31, 2019
From: NUMAB INNOVATION AG
To: NUMAB THERAPEUTICS AG
Reel/Frame 049922/0697 →